Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: A meta-analysis
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 113 (2-3), 181-188
- https://doi.org/10.1016/j.schres.2009.06.010
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Cannabis use and risk of psychotic or affective mental health outcomes: a systematic reviewThe Lancet, 2007
- Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorderJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trialSchizophrenia Research, 2005
- Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking BehaviorNeuropsychopharmacology, 2004
- Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapseSchizophrenia Research, 2002
- Substance Misuse in Patients with SchizophreniaDrugs, 2002
- The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet studyLife Sciences, 1995
- Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of tourette syndrome and other motor disordersLife Sciences, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970